GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
H

Hubei Kailong Chemical Group Co 002783.SZ · CNY

Materials · Shenzhen · 🇨🇳 China

Compare

7.45

+0.68%

Close of 9 Nov 2026, in CNY

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in CNY, from our data supplier.

FY2025

Revenue

CN¥3.54bn

FY2016FY2025

Net income

CN¥142.4m

FY2016FY2025

Free cash flow

CN¥374.1m

FY2016FY2025

Shareholders' equity

CN¥2.63bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenueCN¥3.54bnCN¥3.69bnCN¥3.78bnCN¥3.41bnCN¥2.76bnCN¥2.01bnCN¥1.89bnCN¥1.87bnCN¥1.36bnCN¥953.7m
Gross profitCN¥1.07bnCN¥1.07bnCN¥1.02bnCN¥800.5mCN¥625.4mCN¥545.9mCN¥686.3mCN¥626.3mCN¥500.1mCN¥395.5m
Research and developmentCN¥98.4mCN¥87.8mCN¥80.7mCN¥66.9mCN¥45.5mCN¥30.0mCN¥50.9mCN¥40.0mCN¥41.4mCN¥30.1m
Operating incomeCN¥444.5mCN¥347.0mCN¥330.3mCN¥181.4m−CN¥478.6mCN¥135.0mCN¥151.6mCN¥175.7mCN¥173.8mCN¥143.3m
Net incomeCN¥142.4mCN¥148.2mCN¥175.4mCN¥133.3m−CN¥394.7mCN¥50.3mCN¥50.0mCN¥81.8mCN¥115.0mCN¥108.8m
Diluted earnings per share0.290.330.470.34-1.200.130.150.230.330.32

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsCN¥8.58bnCN¥8.06bnCN¥7.46bnCN¥7.46bnCN¥6.81bnCN¥6.70bnCN¥4.41bnCN¥3.81bnCN¥2.39bnCN¥1.90bn
Cash and short-term investments—CN¥1.05bnCN¥540.7mCN¥998.3mCN¥621.0mCN¥892.4mCN¥845.7mCN¥1.13bnCN¥298.2mCN¥277.9m
Total liabilitiesCN¥4.82bnCN¥4.48bnCN¥4.96bnCN¥5.21bnCN¥4.73bnCN¥4.06bnCN¥2.18bnCN¥1.87bnCN¥734.6mCN¥338.5m
DebtCN¥1.31bnCN¥1.57bnCN¥1.75bnCN¥2.73bnCN¥2.41bnCN¥2.33bnCN¥1.32bnCN¥1.23bnCN¥360.0mCN¥65.7m
Shareholders' equityCN¥2.63bnCN¥2.53bnCN¥1.57bnCN¥1.43bnCN¥1.29bnCN¥1.72bnCN¥1.71bnCN¥1.51bnCN¥1.39bnCN¥1.34bn
Shares outstanding483m452m375m391m330m385m326m356m350m335m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operationsCN¥516.1mCN¥402.1mCN¥488.9mCN¥262.7mCN¥9.7mCN¥98.5mCN¥281.4mCN¥236.1mCN¥156.4mCN¥145.9m
Capital spending−CN¥142.0m−CN¥209.0m−CN¥484.4m−CN¥234.5m−CN¥258.7m−CN¥285.1m−CN¥609.3m−CN¥326.9m−CN¥165.4m−CN¥42.7m
Free cash flowCN¥374.1mCN¥193.1mCN¥4.6mCN¥28.2m−CN¥249.0m−CN¥186.6m−CN¥327.9m−CN¥90.8m−CN¥9.0mCN¥103.2m
Dividends paid−CN¥114.1m−CN¥235.2m−CN¥159.8m−CN¥115.1m−CN¥38.2m−CN¥37.8m−CN¥66.8m−CN¥70.6m−CN¥80.3m−CN¥49.0m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
RevenueCN¥997.5mCN¥715.3mCN¥975.3mCN¥827.9mCN¥976.9mCN¥763.9mCN¥1.12bnCN¥930.8m
Gross profitCN¥312.5mCN¥186.4mCN¥278.8mCN¥264.1mCN¥320.9mCN¥208.7mCN¥302.2mCN¥291.5m
Operating incomeCN¥136.0mCN¥45.3mCN¥95.8mCN¥82.4mCN¥143.2mCN¥81.0mCN¥71.8mCN¥92.5m
Net incomeCN¥67.4mCN¥9.6mCN¥7.3mCN¥28.2mCN¥70.9mCN¥36.0mCN¥36.2mCN¥46.9m
Diluted earnings per share0.140.020.020.060.150.070.080.10
Cash from operations———CN¥1.0mCN¥226.0mCN¥52.0m—−CN¥26.0m
Capital spending−CN¥24.0m−CN¥34.0m−CN¥31.0m−CN¥14.0m−CN¥24.0m−CN¥72.0m−CN¥54.0m−CN¥67.0m
Free cash flow———−CN¥13.0mCN¥202.0m−CN¥20.0m—−CN¥93.0m
Total assetsCN¥8.40bnCN¥8.25bnCN¥8.58bnCN¥8.20bnCN¥8.20bnCN¥8.28bnCN¥8.06bnCN¥8.32bn
Cash and short-term investments———CN¥1.08bnCN¥1.10bnCN¥1.18bnCN¥1.05bnCN¥1.31bn
DebtCN¥1.14bnCN¥900.7mCN¥1.31bnCN¥1.55bnCN¥1.79bnCN¥2.04bnCN¥1.55bnCN¥2.11bn
Shareholders' equityCN¥2.68bnCN¥2.66bnCN¥2.63bnCN¥2.62bnCN¥2.59bnCN¥2.56bnCN¥2.53bnCN¥2.48bn

Financial ratios

Data as of 16 Oct 2026

FY2025FY2024FY2023FY2022FY2021FY2020
Gross margin30.3%28.9%26.9%23.5%22.7%27.1%
Operating margin12.2%11.1%12.0%9.8%-13.0%10.3%
Net margin4.0%4.0%4.6%3.9%-14.3%2.5%
Return on equity5.4%5.8%11.2%9.3%-30.6%2.9%
Return on assets1.7%1.8%2.3%1.8%-5.8%0.8%
Free cash flow yield17.6%17.5%33.6%16.5%10.5%12.9%
Revenue growth-3.9%-2.5%10.9%23.4%37.2%6.3%
Earnings growth-3.9%-15.5%31.5%-133.8%-884.0%0.7%
Current ratio1.01x0.88x0.58x0.63x0.60x0.65x
Debt to equity0.50x0.61x1.38x1.90x1.61x1.35x
Equity ratio30.7%31.4%21.1%19.2%18.9%25.7%
Interest coverage5.58x3.43x3.02x2.29x-2.86x2.34x
R&D as a share of sales2.8%2.4%2.1%2.0%1.6%1.5%
Buybacks as a share of market value-6.8%-20.7%4.1%-18.4%14.3%-18.1%

Growth per year

Compound annual rate

3 years5 years10 years
Revenue1.3%12.0%14.8%
Operating income34.8%26.9%13.5%
Net income2.2%23.1%3.9%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin29.6%27.4%26.7%29.3%
Operating margin10.9%9.0%5.0%6.6%
Net margin4.0%4.2%1.3%2.7%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings32.424.924.824.9-9.076.876.728.035.064.3
Price to sales1.31.01.11.01.31.92.01.23.07.3

Dividends and splits

Per share, in the currency the company pays

Paid for 3 years. Last went ex-dividend on 11 Jun 2026.

FY2026FY2025FY2024FY2023FY2021FY2020FY2019FY2018
Paid in the year0.100.100.100.100.100.100.200.125
  • 8-for-5 split · 29 May 2018
  • 5-for-2 split · 26 May 2017

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.